43 -1 (39) 2022 — Raxmatova D. I., Narzilloeva S. J. — DIAGNOSTICS OF PERFORMANCE DISTURBANCES OF THE CENTRAL NERVOUS SYSTEM IN ISCHEMIC STROKE USING THE DEFINITION COGNITIVE DYSFUNCTION

DIAGNOSTICS OF PERFORMANCE DISTURBANCES OF THE CENTRAL NERVOUS SYSTEM IN ISCHEMIC STROKE USING THE DEFINITION COGNITIVE DYSFUNCTION

Raxmatova D. I., Bukhara State Medical Institute

Narzilloeva S. J. Bukhara State Medical Institute

Resume

A stroke is the main factor in the development of cognitive impairment. Cognitive dysfunctions are one of the earliest manifestations of nervous system dysfunction. In clinica lpractice, it is customary to use various psychophysiological tests and their combinations. The article describes the results of using the MMSE and MoCA scales. The study included 53 patients (23 women and 30 men) aged 55 to 75 years.

Key words:cognitive dysfunctions, scales, MMSE, MoCA

First page

225

Last page

229

For citation: Raxmatova D. I., Narzilloeva S. J. DIAGNOSTICS OF PERFORMANCE DISTURBANCES OF THE CENTRAL NERVOUS SYSTEM IN ISCHEMIC STROKE USING THE DEFINITION COGNITIVE DYSFUNCTION //New Day in Medicine 1(39) 2022 225-229 https://cutt.ly/uO49ETQ

LIST OF REFERENCES:

1. Левин О.С., Васенина Е.Е., Трусова Н.А., Чимагомедова А.Ш. Современные подходы к диагностике и лечению постинсультных когнитивных нарушений. //Пожилой пациент, 2016, 1(5): 9-16. [Levin O.S., Vasenina Ye.Ye., Trusova N.A., Chimagomedova A.SH. Sovremennyye podkhody k diagnostike i lecheniyu postinsul’tnykh kognitivnykh narusheniy. //Pozhiloy patsiyent, 2016, 1(5): 9-16.]
2. Kazakov B.Sh. Morphofunctional factors leading to individual formation of covid-19-associated ischemic stroke //New Day in Medicine 5(37)2021 122-124 https://cutt.ly/wT8xC0p
3. Kazakov B.Sh., Khodjieva D.T. Clinical and Neurological Factors in the Formation of Individual Predisposition to Covid-Associated Ischemic Stroke // American Journal of Medicine and Medical Sciences 2021, 11(2): P. 130-133.
4. Davronova Kh. Z. Assessment of Pathogenetic Factors of Cerebrovascular Pathology in Type 2 Diabetes Mellitus // International Journal of InnovativeAnalyses and Emerging Technology. Volume: 1 Issue: 4 inSeptember2021
5. Gorelick P.B. The global burden of stroke: persistent and disabling // The Lancet Neurology.2019;18(5):417–8.)
6. Jacquin A., Binquet C., Rouaud O., et al. Poststroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke // J. Alzheimers Dis. 2014; 40(4): 1029-38. doi: 10.3233/JAD-131580.
7. Jokinen H., Melkas S., Ylikoski R., et al. Poststroke cognitive impairment is common even after successful clinical recovery. //Eur J Neurol. 2015 Sep; 22(9):1288-94. doi: 10.1111/ene.12743.Epub 2015 Jun 4
8. Mendis S. Stroke disability and rehabilitation ofstroke: World Health Organization perspective. //Intern J Stroke, 2013, 8(1): 3-4.
9. Rist P.M., Chalmers J., Arima H., et al. Baseline cognitive function, recurrent stroke, and risk ofdementia in patients with stroke. // Stroke. 2013 Jul; 44(7):1790-5.doi:10.1161/STROKEAHA.111. 680728. Epub 2013 May 16.
10. Urinov M.B. Assessment of the State of the Emotional Sphere and the Dynamics of Cognitive Functions on the Background of Rehabilitation Treatment in theAcute Period Acute Cerebrovascular Disorders // International Journal of Pharmaceutical and Bio-Medical Science. Volume 01 Issue 05 August 2021. P. 65-67
11. Urinov M.B. Evaluation of the Efficiency of the Complex of Rehabilitation Treatment forthe Outcome of the Early Period after Acute Cerebral Circulation Disorders // International Journal of Medical Science and Clinical Research Studies. Volume 01 Issue 06 August 2021. P. 135-137
12. Urinov M.B., Alikulova N., Zukhritdinova D., Usmonov M., UrinovR. Clinical, Laboratory and Instrumental Indicators in Patients who have undergone COVID-19 // International Journal of Health Science. Vol. 5 No. 3, December 2021, P: 403-398